Plus, news about InxMed, Marker Therapeutics, PDS Biotech, Shattuck Labs, Pfizer, BioInvent and Celyad Oncology:
💊 Incannex’s psilocybin treatment passes Phase 2 anxiety trial: The biotech’s psilocybin-assisted psychotherapy candidate, PSX-001,
↧